cladribine has been researched along with EBV Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrada, FC; Clauze, A; Cooper, JF; Hughes, RJ; Jacobson, S; Lieberman, PM; Lu, F; Messick, TE; Monaco, MCG; Ohayon, J; Patel, RJ; Soldan, SS; Su, C | 1 |
| Golf, A; Haferlach, T; Hiddemann, W; Lenz, G; Rüdiger, T | 1 |
2 other study(ies) available for cladribine and EBV Infections
| Article | Year |
|---|---|
EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls.
Topics: Case-Control Studies; Cell Line; Cell Proliferation; Cladribine; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Herpesvirus 4, Human; Humans; Multiple Sclerosis | 2023 |
Epstein-Barr virus-associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribine.
Topics: Antineoplastic Agents; Cladribine; Epstein-Barr Virus Infections; Humans; Leukemia, Hairy Cell; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasms, Second Primary | 2003 |